Travere Therapeutics
TVTX
$5.46
Share price
3.80%
Change (1 day)
-75.85%
Change (1 year)
Categories
Travere Therapeutics (TVTX) - Total debt
Total debt on the balance sheet as of December 2023 : $0.40 B
According to Travere Therapeutics's latest financial reports the company's total debt is $0.40 B. A company’s total debt is the sum of all current and non-current debts.
Travere Therapeutics - Total debt on balance sheet (from 2011 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.40 B | -0.66% |
| 2022-12-31 | $0.40 B | 55.54% |
| 2021-12-31 | $0.26 B | 7.36% |
| 2020-12-31 | $0.24 B | 19.12% |
| 2019-12-31 | $0.20 B | -5.83% |
| 2018-12-31 | $0.21 B | 382.61% |
| 2017-12-31 | $45.07 M | 1.47% |
| 2016-12-31 | $44.42 M | 1.5% |
| 2015-12-31 | $43.76 M | -47.76% |
| 2014-12-31 | $83.77 M | |
| 2012-12-31 | $0.88 M | |
| 2012-02-29 | $0.02 M | |
| 2011-02-28 | $0.02 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.32 B | -19.32% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |